Non-CME/CE Industry
Nephrology
Cardiovascular-Kidney-Metabolic (CKM) syndrome presents significant diagnostic and management challenges for primary healthcare providers due to its heterogeneous presentation and overlap with conditions such as heart failure, chronic kidney disease, diabetes, and obesity. This program provides practical, evidence-based education on the definition, screening, staging, and management of CKM syndrome, including emerging therapies, to support primary care physicians, advanced practice providers, and pharmacists in delivering coordinated patient care.
Bayer U.S.